葵花药业 - Financials

葵花药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
+Revenue	3.4B	5.7B	5.1B	4.5B	3.5B	4.4B	4.5B	3.9B	3.4B	3.0B	2.7B	2.2B	1.8B	1.6B
Revenue Growth %	-40.8%	11.9%	14.2%	28.9%	-20.8%	-2.3%	16.0%	14.6%	10.8%	11.6%	24.7%	23.2%	13.5%	--
Total Revenue	3.4B	5.7B	5.1B	4.5B	3.5B	4.4B	4.5B	3.9B	3.4B	3.0B	2.7B	2.2B	1.8B	1.6B
Cost Of Revenue	1.9B	2.5B	2.2B	1.8B	1.4B	1.8B	1.8B	1.6B	1.4B	1.3B	1.0B	786.0M	660.0M	557.0M
+Gross Profit	1.5B	3.2B	2.9B	2.6B	2.0B	2.6B	2.6B	2.3B	2.0B	1.7B	1.7B	1.4B	1.1B	1.0B
Gross Margin %	44.9%	56.3%	57.8%	59.3%	58.1%	58.5%	59.1%	59.6%	58.4%	55.6%	62.0%	64.0%	62.7%	64.3%
Total Operating Cost	2.9B	4.5B	4.1B	3.7B	2.8B	3.7B	3.8B	3.4B	3.0B	2.7B	2.3B	1.9B	1.5B	1.3B
Selling Expenses	431.0M	1.4B	1.3B	1.2B	873.0M	1.3B	1.4B	1.3B	1.2B	1.0B	993.0M	815.0M	600.0M	560.0M
Admin Expenses	423.0M	473.0M	476.0M	467.0M	319.0M	375.0M	361.0M	334.0M	372.0M	290.0M	233.0M	185.0M	176.0M	164.0M
Rd Expenses	124.0M	129.0M	94.6M	132.0M	114.0M	118.0M	122.0M	110.0M	--	--	--	--	--	--
Finance Expenses	-23.1M	-32.0M	-11.2M	-9.9M	-7.2M	-1.6M	147,900	7.2M	7.9M	1.4M	31.9M	37.0M	40.8M	33.4M
+Operating Income	636.0M	1.4B	1.1B	885.0M	767.0M	760.0M	716.0M	555.0M	343.0M	341.0M	383.0M	308.0M	265.0M	221.0M
Operating Margin %	18.8%	24.0%	21.3%	19.8%	22.2%	17.4%	16.0%	14.4%	10.2%	11.2%	14.1%	14.1%	15.0%	14.2%
Non Operating Income	7.2M	2.6M	2.8M	16.5M	11.5M	21.9M	21.0M	15.4M	82.9M	62.3M	24.0M	41.6M	33.3M	37.9M
Non Operating Expenses	8.9M	14.7M	6.7M	7.1M	11.3M	4.3M	16.3M	5.7M	3.2M	1.7M	443,100	2.5M	5.0M	2.8M
Investment Income	24.9M	47.0M	9.4M	23.7M	14.2M	11.0M	10.5M	7.5M	4.6M	8.5M	227,500	201,200	210,000	151,700
Fair Value Change Income	-13.0M	-16.4M	-19.3M	2.7M	--	--	--	--	--	--	--	--	--	--
Asset Disposal Income	-240,200	3.2M	7.4M	47.8M	-5.4M	3.5M	25.5M	3.9M	-412,400	--	--	--	--	--
Asset Impairment Loss	56.9M	978,200	29.4M	32.4M	37.4M	18.8M	11.1M	5.8M	17.7M	1.3M	9.1M	22.8M	5.3M	1.1M
Other Income	176.0M	127.0M	83.4M	57.0M	126.0M	49.0M	54.5M	48.6M	--	--	--	--	--	--
Income Before Tax	634.0M	1.4B	1.1B	895.0M	767.0M	778.0M	720.0M	565.0M	422.0M	401.0M	407.0M	347.0M	293.0M	256.0M
Income Tax	132.0M	190.0M	171.0M	132.0M	147.0M	143.0M	113.0M	94.9M	83.1M	73.6M	75.9M	64.4M	45.1M	57.1M
+Net Income	503.0M	1.2B	910.0M	762.0M	620.0M	635.0M	608.0M	470.0M	339.0M	328.0M	331.0M	283.0M	248.0M	199.0M
Net Margin %	14.9%	20.4%	17.9%	17.1%	17.9%	14.5%	13.6%	12.2%	10.1%	10.8%	12.2%	13.0%	14.0%	12.8%
Net Income Attributable	492.0M	1.1B	867.0M	705.0M	584.0M	565.0M	563.0M	424.0M	303.0M	307.0M	301.0M	263.0M	234.0M	191.0M
Minority Interest	10.7M	45.8M	42.5M	57.6M	35.5M	69.7M	44.5M	45.9M	36.2M	20.9M	30.0M	19.6M	13.5M	8.1M
Eps Basic	0.84	1.92	1.48	1.21	1.00	0.97	0.96	0.73	1.04	1.05	1.38	2.40	2.14	1.74
Eps Diluted	0.84	1.92	1.48	1.21	1.00	0.97	0.96	0.73	1.04	1.05	1.38	2.40	2.14	1.74

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash And Equivalents	1.0B	2.3B	2.4B	1.3B	1.6B	1.5B	1.2B	932.0M	906.0M	969.0M	1.8B	439.0M	492.0M	340.0M
Trading Financial Assets	1.3B	1.3B	1.4B	669.0M	150.0M	205.0M	--	--	--	--	--	--	--	--
Accounts Receivable	208.0M	66.3M	152.0M	195.0M	128.0M	388.0M	263.0M	317.0M	361.0M	325.0M	227.0M	187.0M	115.0M	56.3M
Notes Receivable	7.4M	8.0M	--	--	15.0M	30.4M	355.0M	170.0M	152.0M	127.0M	78.3M	10.5M	12.3M	10.5M
Notes And Accounts Receivable	215.0M	74.3M	152.0M	195.0M	143.0M	419.0M	619.0M	487.0M	513.0M	452.0M	305.0M	198.0M	128.0M	66.7M
Prepayments	56.3M	94.5M	144.0M	95.0M	55.7M	61.1M	72.0M	58.9M	97.7M	54.1M	40.9M	55.6M	37.0M	71.2M
Inventory	867.0M	873.0M	632.0M	710.0M	562.0M	665.0M	814.0M	797.0M	648.0M	537.0M	351.0M	347.0M	330.0M	281.0M
Total Current Assets	3.9B	4.8B	4.9B	3.4B	2.9B	3.1B	3.1B	2.6B	2.5B	2.1B	2.6B	1.1B	1.0B	802.0M
Long Term Equity Investment	43.2M	45.4M	47.9M	29.3M	--	--	--	--	--	--	--	--	1.8M	1.8M
Fixed Assets	--	1.4B	1.4B	1.5B	1.4B	1.2B	1.2B	1.2B	1.2B	1.1B	737.0M	604.0M	484.0M	427.0M
Fixed Assets Total	1.3B	1.4B	1.4B	1.5B	1.4B	1.2B	1.2B	1.2B	1.2B	1.1B	737.0M	604.0M	484.0M	427.0M
Construction In Progress	--	35.7M	30.3M	19.1M	217.0M	322.0M	134.0M	44.7M	16.8M	116.0M	181.0M	155.0M	121.0M	93.5M
Construction In Progress Total	30.8M	35.7M	30.3M	19.1M	217.0M	322.0M	134.0M	44.7M	16.8M	116.0M	181.0M	155.0M	121.0M	93.5M
Intangible Assets	333.0M	345.0M	367.0M	338.0M	351.0M	385.0M	395.0M	330.0M	283.0M	281.0M	185.0M	190.0M	188.0M	171.0M
Long Term Deferred Expenses	10.0M	8.9M	6.8M	1.9M	3.8M	5.4M	3.7M	4.0M	4.8M	3.0M	2.8M	2.4M	2.6M	2.5M
Total Non Current Assets	1.9B	2.1B	2.2B	2.2B	2.2B	2.2B	2.0B	1.8B	1.7B	1.7B	1.2B	1.0B	859.0M	755.0M
Total Assets	5.8B	6.9B	7.0B	5.6B	5.1B	5.3B	5.1B	4.5B	4.2B	3.8B	3.7B	2.1B	1.9B	1.6B
Short Term Borrowings	22,100	14.4M	420.0M	200.0M	241.0M	300.0M	150.0M	100.0M	330.0M	203.0M	553.0M	555.0M	587.0M	545.0M
Accounts Payable	319.0M	735.0M	714.0M	541.0M	448.0M	529.0M	437.0M	368.0M	334.0M	276.0M	163.0M	187.0M	131.0M	140.0M
Advance Receipts	1.6M	--	--	--	133,700	102.0M	185.0M	121.0M	70.5M	66.1M	10.0M	2.7M	937,300	76,400
Contract Liabilities	284.0M	297.0M	552.0M	167.0M	121.0M	--	--	--	--	--	--	--	--	--
Total Current Liabilities	1.0B	1.5B	2.2B	1.3B	1.2B	1.3B	1.2B	952.0M	1.1B	849.0M	1.1B	972.0M	971.0M	829.0M
Long Term Borrowings	--	--	--	33.6M	70.0M	126.0M	46.3M	--	--	--	157.0M	97.3M	98.1M	163.0M
Total Non Current Liabilities	208.0M	357.0M	418.0M	447.0M	565.0M	563.0M	408.0M	357.0M	348.0M	305.0M	399.0M	258.0M	165.0M	184.0M
Total Liabilities	1.2B	1.9B	2.6B	1.7B	1.7B	1.9B	1.6B	1.3B	1.4B	1.2B	1.5B	1.2B	1.1B	1.0B
Paid In Capital	584.0M	584.0M	584.0M	584.0M	584.0M	584.0M	584.0M	292.0M	292.0M	292.0M	146.0M	109.0M	109.0M	109.0M
Capital Reserve	918.0M	916.0M	890.0M	897.0M	930.0M	890.0M	896.0M	1.2B	1.2B	1.2B	1.4B	155.0M	148.0M	138.0M
Surplus Reserve	300.0M	300.0M	300.0M	300.0M	300.0M	265.0M	224.0M	187.0M	144.0M	115.0M	83.5M	83.5M	67.5M	52.7M
Retained Earnings	2.6B	3.0B	2.4B	2.0B	1.5B	1.5B	1.5B	1.3B	1.0B	832.0M	608.0M	471.0M	400.0M	223.0M
Minority Equity	211.0M	241.0M	234.0M	226.0M	211.0M	206.0M	164.0M	169.0M	167.0M	161.0M	63.4M	40.7M	25.4M	14.3M
Equity Attributable	4.4B	4.8B	4.2B	3.7B	3.2B	3.2B	3.3B	3.0B	2.6B	2.4B	2.2B	828.0M	733.0M	529.0M
Total Equity	4.6B	5.0B	4.4B	3.9B	3.4B	3.4B	3.4B	3.2B	2.8B	2.6B	2.3B	869.0M	758.0M	543.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash From Sales	3.1B	6.2B	6.2B	4.9B	4.1B	4.4B	5.0B	4.2B	3.8B	3.4B	3.0B	2.5B	2.0B	1.8B
Tax Refunds Received	--	--	--	--	--	13.6M	22.1M	9.7M	8.2M	10.4M	--	--	--	--
Total Operating Cash Inflow	3.3B	6.3B	6.4B	5.1B	4.3B	4.7B	5.3B	4.4B	4.0B	3.5B	3.1B	2.6B	2.1B	1.9B
Cash Paid For Goods	1.6B	2.5B	1.9B	1.8B	1.3B	1.4B	1.8B	1.4B	1.5B	1.4B	1.0B	809.0M	651.0M	632.0M
Cash Paid To Employees	646.0M	612.0M	566.0M	527.0M	393.0M	475.0M	484.0M	447.0M	363.0M	323.0M	321.0M	273.0M	247.0M	236.0M
Taxes Paid	459.0M	723.0M	580.0M	565.0M	437.0M	507.0M	627.0M	583.0M	501.0M	430.0M	393.0M	361.0M	280.0M	261.0M
Total Operating Cash Outflow	3.6B	5.4B	4.4B	4.2B	3.1B	3.7B	4.4B	3.8B	3.6B	3.4B	2.7B	2.3B	1.8B	1.6B
Operating Cash Flow	-307.0M	890.0M	2.0B	865.0M	1.2B	981.0M	866.0M	567.0M	341.0M	126.0M	403.0M	293.0M	327.0M	258.0M
Total Investing Cash Inflow	4.9B	2.3B	2.2B	1.2B	762.0M	571.0M	504.0M	44.8M	45.8M	444.0M	55.2M	89.7M	13.4M	398,900
Total Investing Cash Outflow	4.9B	2.3B	2.8B	2.1B	966.0M	884.0M	791.0M	199.0M	420.0M	702.0M	200.0M	194.0M	115.0M	199.0M
Investing Cash Flow	2.5M	36.2M	-644.0M	-890.0M	-204.0M	-314.0M	-287.0M	-154.0M	-374.0M	-259.0M	-145.0M	-105.0M	-102.0M	-199.0M
Cash From Borrowings	--	10.0M	420.0M	307.0M	351.0M	450.0M	216.0M	215.0M	330.0M	190.0M	701.0M	608.0M	674.0M	717.0M
Dividends And Interest Paid	926.0M	627.0M	451.0M	242.0M	624.0M	621.0M	322.0M	129.0M	125.0M	82.0M	231.0M	210.0M	93.5M	145.0M
Debt Repayments	10.0M	420.0M	234.0M	383.0M	466.0M	220.0M	120.0M	449.0M	203.0M	799.0M	640.0M	641.0M	672.0M	518.0M
Total Financing Cash Inflow	22,100	14.4M	442.0M	335.0M	391.0M	450.0M	218.0M	215.0M	376.0M	223.0M	2.0B	616.0M	674.0M	787.0M
Total Financing Cash Outflow	943.0M	1.1B	689.0M	644.0M	1.2B	878.0M	469.0M	618.0M	371.0M	944.0M	871.0M	852.0M	770.0M	743.0M
Financing Cash Flow	-943.0M	-1.0B	-247.0M	-309.0M	-784.0M	-428.0M	-252.0M	-403.0M	4.4M	-721.0M	1.1B	-235.0M	-95.5M	44.4M
Net Change In Cash	-1.2B	-113.0M	1.1B	-334.0M	182.0M	240.0M	328.0M	9.5M	-28.3M	-854.0M	1.4B	-46.9M	130.0M	103.0M
Ending Cash Balance	1.0B	2.3B	2.4B	1.3B	1.6B	1.5B	1.2B	898.0M	888.0M	917.0M	1.8B	417.0M	464.0M	334.0M
Capex	92.8M	149.0M	153.0M	118.0M	213.0M	374.0M	321.0M	157.0M	159.0M	177.0M	198.0M	194.0M	114.0M	199.0M